IDXX IDEXX Laboratories, Inc.

NASDAQ
$517.75

IDEXX Laboratories, Inc. (IDXX) is confirmed to report earnings on November 2, 2026, before the market open. The consensus earnings estimate is $3.70 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -14.0% since its last earnings release on August 4, 2026.

IDEXX Laboratories Beat Consensus Estimates, Raises Earnings Guidance
Tuesday, August 4, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 6:30 AM ET
Earnings Whisper
-
vs $3.70
Rev est $1.19B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $545.09

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About IDEXX Laboratories, Inc.

IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for the veterinary, bioresearch, water, livestock, poultry and dairy markets.

Sector

Healthcare

Industry

Diagnostic Substances

Held By 6 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.